Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

PFIZER INC.

🇺🇸United States

Country: 🇺🇸United States

Ownership: Public

Established: 1849-01-01

Employees: 88K

Market Cap: $163.3B

Website: http://www.pfizer.com

Clinical Trials

Phase I Study Of The Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Of Multiple Intravenously Administered Doses Of PF-04236921 In Patients With Rheumatoid Arthritis

Phase 1

Completed

Conditions: Rheumatoid Arthritis

Interventions: Drug: Placebo
Drug: dose level 1
Drug: dose level 2
Drug: dose level 3
Drug: dose level 4

First Posted Date: 2009-02-06

Last Posted Date: 2018-11-02

Lead Sponsor: Pfizer

Target Recruit Count: 41

Registration Number: NCT00838565

Locations: 🇺🇸
Allergy, Asthma, Arthritis, & Lung, Daytona Beach, Florida, United States
🇺🇸
Millennium Research, Ormond Beach, Florida, United States
🇺🇸
Altoona Center for Clinical Research, Duncansville, Pennsylvania, United States

and more 5 locations

A Phase 3 Study To Evaluate The Safety And Tolerability Of Dimebon Patients With Mild To Moderate Alzheimer's Disease

Phase 3

Completed

Conditions: Alzheimer's Disease

Interventions: Drug: Placebo
Drug: Dimebon

First Posted Date: 2009-02-06

Last Posted Date: 2018-12-06

Lead Sponsor: Pfizer

Target Recruit Count: 742

Registration Number: NCT00838110

Locations: 🇵🇷
Pfizer Investigational Site, San Juan, Puerto Rico

Axitinib (AG-013736) With Or Without Dose Titration (Increase) In Patients With Kidney Cancer

Phase 2

Completed

Conditions: Carcinoma, Renal Cell

Interventions: Drug: axitinib

First Posted Date: 2009-02-04

Last Posted Date: 2017-05-30

Lead Sponsor: Pfizer

Target Recruit Count: 213

Registration Number: NCT00835978

Locations: 🇺🇸
East Bay Medical Oncology/Hematology Medical Associates Inc., Antioch, California, United States
🇺🇸
Comprehensive Blood and Cancer Center, Bakersfield, California, United States
🇺🇸
Bay Area Cancer Research Group, LLC, Pleasant Hill, California, United States

and more 60 locations

A Multiple Dose Trial Evaluating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of PF-04457845 in Healthy Volunteers

Phase 1

Completed

Conditions: Acute Pain
Chronic Pain

Interventions: Drug: PF-04457845, FAAH inhibitor

First Posted Date: 2009-02-04

Last Posted Date: 2009-08-06

Lead Sponsor: Pfizer

Target Recruit Count: 41

Registration Number: NCT00836082

Locations: 🇸🇬
Pfizer Investigational Site, Singapore, Singapore

A Study To Evaluate The Safety Of Voriconazole As Treatment Of Invasive Aspergillosis (Fungal Infection) And Other Rare Molds In Children

Phase 3

Terminated

Conditions: Invasive Aspergillosis

Interventions: Drug: Voriconazole

First Posted Date: 2009-02-04

Last Posted Date: 2017-06-16

Lead Sponsor: Pfizer

Target Recruit Count: 31

Registration Number: NCT00836875

Locations: 🇺🇸
Childrens Hospital Los Angeles, Los Angeles, California, United States
🇺🇸
Children's Hospital & Research Center Oakland (CHRCO), Oakland, California, United States
🇺🇸
Children's Hospital of Pittsburgh of UPMC, Pittsburgh, Pennsylvania, United States

and more 21 locations

Non-Interventional Study Of Indian Patients With Advanced Renal Cell Cancer Receiving Therapy With Sutent

Completed

Conditions: Renal Cell Carcinoma

First Posted Date: 2009-02-04

Last Posted Date: 2013-12-20

Lead Sponsor: Pfizer

Target Recruit Count: 36

Registration Number: NCT00836745

Locations: 🇮🇳
Pfizer Investigational Site, Jaipur, India

Post Marketing Observational Study of Reformulated BeneFIX

Completed

Conditions: Hemophilia B

First Posted Date: 2009-02-03

Last Posted Date: 2014-09-17

Lead Sponsor: Pfizer

Target Recruit Count: 58

Registration Number: NCT00835068

Locations: 🇫🇷
Pfizer Investigational Site, Vandoeuvre Les Nancy Cedex, France

Multiple Dose Study To Investigate The Effects Of Fesoterodine And Solifenacin On Gastrointestinal Transit

Phase 1

Terminated

Conditions: Healthy

Interventions: Drug: fesoterodine fumarate
Drug: placebo
Drug: solifenacin

First Posted Date: 2009-01-30

Last Posted Date: 2010-12-24

Lead Sponsor: Pfizer

Target Recruit Count: 60

Registration Number: NCT00832650

Locations: 🇺🇸
Pfizer Investigational Site, Rochester, Minnesota, United States

Study Evaluating Long-Term Safety of Desvenlafaxine Succinate Sustained Release With Japanese Adult Subjects in Major Depressive Disorder (MDD)

Phase 3

Completed

Conditions: Major Depressive Disorder

Interventions: Drug: desvenlafaxine succinate sustained release tablets

First Posted Date: 2009-01-29

Last Posted Date: 2018-12-07

Lead Sponsor: Pfizer

Target Recruit Count: 304

Registration Number: NCT00831415

Locations: 🇯🇵
Pfizer Investigational Site, Tokyo, Japan

Study To Evaluate The Pharmacokinetics, Safety, And Tolerability Of Dimebon [Pf-01913539] In Subjects With Hepatic Impairment And Normal Hepatic Function

Phase 1

Completed

Conditions: Hepatic Failure

Interventions: Drug: Dimebon

First Posted Date: 2009-01-29

Last Posted Date: 2009-09-16

Lead Sponsor: Pfizer

Target Recruit Count: 23

Registration Number: NCT00831532

Locations: 🇺🇸
Pfizer Investigational Site, Indianapolis, Indiana, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy